CROI 2019 Program and Conference Information

Oral Sessions

44 NEONATAL ART<7 DAYS VS 7-28 DAYS REDUCED TIME TO SUPPRESSION Alfredo Tagarro, Sara Dominguez Rodriguez, Thanyawee Puthanakit, Paolo Palma, Caroline Foster, Thidarat Jupimai, Nicola Cotugno, Jintanat Ananworanich, Santiago Jimenez de Ory, Paola Zangari, Maria Luisa Navarro, Paolo Rossi, Eleni Nastuoli, Carlo Giaquinto, Pablo Rojo Conejo, for the EPIICAL Consortium SAFETY AND PHARMACOKINETICS OFMONOCLONAL ANTIBODY, VRC01LS, INHIV-EXPOSED NEWBORNS Elizabeth J. McFarland, Coleen K. Cunningham, Edmund V. Capparelli, Petronella Muresan, Elizabeth Smith, Charlotte Perlowski, Leavitt Morrison, Patricia Morgan, Adrian B. McDermott, Rohan Hazra, John R. Mascola, Barney S. Graham, for the IMPAACT P1112 Protocol Team BICTEGRAVIR/FTC/TAF SINGLE-TABLET REGIMEN IN ADOLESCENTS & CHILDREN:WEEK 48 RESULTS Aditya Gaur, Mark Cotton, Carina Rodriguez, Eric J. McGrath, Elizabeth Hellstrom, Afaaf Liberty, Eva Natukunda, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Heather Maxwell, Sophia R. Majeed, Danielle Porter, Pamela Wong, Hiba Graham, Cheryl Pikora Oral Abstract O-05 STRANGE BEDFELLOWS: STIs, CONTRACEPTION, AND TRIALS OF HIV TESTING Room 6AB 10:00 AM - 12:00 PM Oral Abstract Moderators Peter L. Anderson, University of Colorado Anschutz Medical Campus, Aurora, CO, USA INCIDENT SYPHILIS RATES AND PREDICTORS IN USWOMEN WITHHIV, 2005-2016 Jodie Dionne-Odom, AndrewWestfall, Michael J. Mugavero, Sonia Napravnik, Julia C. Dombrowski, Mari Kitahata, Richard D. Moore, Benigno Rodriguez, Maile Y. Karris, Elvin Geng, Kenneth H. Mayer, Jeanne M. Marrazzo PREPARING FOR PrEP IN ENGLAND: PREVALENCE AND INCIDENCE OF HIV AND BACTERIAL STIs Dana Ogaz, Ada R. Miltz, Sarika Desai, John Saunders, Andre Charlett, Owen N. Gill, Hamish Mohammed EXPANDING TESTING STRATEGIES IN PARIS: A FREE POSTAL COMPREHENSIVE STI TEST KIT Delphine Rahib, Heloise M. Delagreverie, Iris Bichard, Audrey Gabassi, Nicolas Guigue, Marie-Laure Chaix Baudier, Beatrice Bercot, Constance Delaugerre, Nathalie Lydié RANDOMIZED CONTROLLED TRIAL OF INTRAUTERINE DEVICE SAFETY INWOMEN LIVINGWITHHIV Catherine S. Todd, Heidi Jones, Nontokozo Langwenya, Donald R. Hoover, Greg Petro, Landon Myer DOUBLE-DOSE LEVONORGESTREL IMPLANT DOES NOT FULLY OVERCOME INTERACTIONWITH EFAVIRENZ Kimberly K. Scarsi, Lauren Cirrincione, Shadia Nakalema, Kristin Darin, Ian Musinguzi, Isabella Kyohairwe, Pauline Byakika-Kibwika, Andrew Owen, Lee Winchester, Anthony Podany, Susan E. Cohn, David Back, Courtney V. Fletcher, Marco Siccardi, Mohammed Lamorde 48 10:15 49 10:30 50 10:45 51 11:00 10:00 11:15 45 11:30 46 11:45 Flavia K. Matovu, Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda 47

Oral Sessions • Tuesday

CROI 2019 35